High Hampton’s Mojave Jane Announces Start Of Production In California January 2019
“While Mojave Jane’s production delivers revenue and cash flow to the Company, it also means realizing the advantages of integrating with High Hampton’s complete portfolio”, commented Gary Latham, High Hampton’s CEO. “That is where the real long term value of this company will be realized.” About Mojave Jane LLC.... Read more
Creso Pharma Brings Together Cannabis Experts Across Several Verticals
Ryan Allway December 18th, 2018 Exclusive, Top News The due diligence process looks very different for small-cap versus large-cap stocks. When analyzing large-cap companies, investors pay closest attention to financial statements and valuation ratios to extrapolate growth rates and apply multiples. Small-cap stocks tend to be earlier stage... Read more
Wiz Khalifa Partners with Supreme to Expand Cannabis Brand
Ryan Allway December 18th, 2018 Exclusive, News, Press Releases, Top News The music industry has become increasingly intertwined with the cannabis industry over the past several years. With the partnership between Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) and Snoop Dogg in 2016, these relationships grew even closer... Read more
Wayland Announces Significant Supply Agreement with RavenQuest BioMed
TORONTO, Dec. 18, 2018 (GLOBE NEWSWIRE) — Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) and RavenQuest BioMed Inc. (“RavenQuest”) are pleased to announce the companies have entered into a supply agreement whereby Wayland will purchase up to 8,000 kg of dried flower cannabis from RavenQuest in... Read more
Biome Grow Receives New Consumer Sales Amendment From Health Canada For Its Nova Scotia brand, Highland Grow.
Ryan Allway December 17th, 2018 News, Top News Sales amendment granted for Highland Grow—Amendment to License Significantly Increases Product Availability for Medical and Adult Consumer-Use Markets Toronto, Ontario (December 17th, 2018) – Biome Grow Inc. (“Biome” or the “Company”) (CSE: BIO) (Frankfurt: 6OTA) (OTC: ORTFF) is pleased to... Read more
Marijuana Stocks Newsletter – December 13, 2018

which marijuana stocks to buy

Marijuana Stocks: They Say The Trend Is Your Friend Have you been paying attention this week? There’s a lot that has happened since the release of our newest Connect The Dots feature and we’re looking to the second half of the week to see what happens next. When we talk about connecting the dots, this […]

The post Marijuana Stocks Newsletter – December 13, 2018 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
Marijuana Stocks Newsletter – December 14, 2018

marijuana stocks to buy

We’ve Seen A Big Week Already; Strong Close Ahead? Have you been paying attention this week? There’s a lot that has happened since the release of our newest Connect The Dots feature and we’re looking to the second half of the week to see what happens next. When we talk about connecting the dots, this […]

The post Marijuana Stocks Newsletter – December 14, 2018 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
How California Can Overcome Its Cannabis Challenges
Ryan Allway December 14th, 2018 Uncategorized California’s cannabis industry is projected to reach $5.1 billion by the end of 2019, according to BDS Analytics, but unexpected challenges have slowed progress. These challenges range from excessive regulations to sky-high taxation. Investors looking for opportunities in the state may want... Read more
Grown Rogue Launches Craft Cannabis Chocolates
Ryan Allway December 14th, 2018 Uncategorized Cannabis and chocolate have a long history together. While “pot brownies” are perhaps the original cannabis edible, professional chefs and food scientists have refined the process of infusing cannabinoids and chocolates to create unique innovations. Investors may want to take a closer... Read more
Canntab Partners with Leading Surgeon to Conduct Pain Management Trial
Ryan Allway December 14th, 2018 Exclusive, Top News The opioid industry is expected to generate nearly $20 billion in annual revenue by 2020, but the addictive nature of the drug has doctors and patients increasingly concerned. With the legalization of cannabis across Canada and many U.S. states, there’s... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )